Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru

Human Immunology

Volumn 71, Issue 8, 2010, Pages 804-808

  Talledo, Michael ^a,b   López, Giovanni ^a   Huyghe, Jeroen R ^b   Verdonck, Kristien ^a,c   González, Elsa ^a,d   Clark, Daniel ^a,d   Senitzer, David ^e   Vanham, Guido ^b,c   Gotuzzo, Eduardo ^a,d   Van Camp, Guy ^b   Van Laer, Lut ^b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

HAM; HLA C; HTLV 1; HTLV 1 associated myelopathy tropical spastic paraparesis; KIR; Peru

Indexed keywords

HLA C ANTIGEN; HLA C1C1 ANTIGEN; HLA C1C2 ANTIGEN; HLA C2C2 ANTIGEN; HLA CW ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC EPISTASIS; GENETIC SUSCEPTIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERU; PRIORITY JOURNAL; RECEPTOR GENE; TROPICAL SPASTIC PARAPARESIS; VIRUS CARRIER; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-C ANTIGENS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARAPARESIS, TROPICAL SPASTIC; PERU; RECEPTORS, KIR2DL3;

EID: 77954757014     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.011     Document Type: Article

References (34)

1. Proietti F., Carneiro-Proietti A., Catalan-Soares B., Murphy E. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068.
2. Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: Recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
3. Adaui V., Best I., González E., Tipismana M., Arévalo J., Vanham G. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol 2006, 12:456-465.
4. Nagai M., Usuku K., Matsumoto W., Kodama D., Takenouchi N., Moritoyo T., et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998, 4:586-593.
5. Sabouri A.H., Usuku K., Bajestan S.N., Mahmoudi M., Forughipour M., Sabouri Z., et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 2005, 86:773-781.
6. + T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A 1998, 95:7568-7573.
7. Denke S. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology 1996, 217:139.
8. Levin MC L.S., Kalume F., Morcos Y., Dohan F.C., Hasty K.A., et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002, 8:509-513.
9. Ndhlovu L.C., Carvalho K.I., Leal F.E., Loo C.P., Bruno F.R., et al. Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. Clin Exp Immunol 2009, 2. S-CJ, September [Epub ahead of print].
10. Fujihara K., Yu F., Kubo C., Goto I. Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 1991, 105:99-107. IY.
11. Yu F., Fujihara K., Goto I. Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals. J Neuroimmunol 1991, 33:121-128. IY.
12. Nelson G.W., Gladman D., Wade J., Trowsdale J., Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004, 173:4273-4276.
13. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5:201-214.
14. Williams F., Sleator C., Cook D., Fernandez-Vina M., Bowcock A.M., Middleton D. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005, 66:836-841.
15. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., Goronzy J.J. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001, 193:1159-1167.
16. Raulet DH V.R., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001, 19:291-330.
17. Gardiner C. Killer cell immunoglobulin-like receptors on NK cells: the how, where and why. Int J Immunogenet 2007, 35:1-8.
18. Williams A., Bateman A., Khakoo S. Hanging in the balance. KIR and their role in disease. Mol Interv 2005, 5:226-240.
19. Martin M.P., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002, 4:429-434. GX.
20. Khakoo S.I., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305:872-874. TC.
21. Estefanía E., Portero F., de Pablo R., Solís R., Sepúlveda S., et al. Influence of KIR gene diversity on the course of HSV-1 infection: resistance to the disease is associated with the absence of KIR2DL2 and KIR2DS2. Tissue Antigens 2007, 70:34-41. G-LN.
22. De Castro-Costa C.M., Araujo A.Q., Barreto M.M., Takayanagui O.M., Sohler M.P., da Silva E.L., et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM). AIDS Res Hum Retrovir 2006, 22:931-935.
23. Osame M. Review of WHO, Kagoshima meeting and diagnostic guidelines for HAM/TSP 1990, 191-197. Raven Press, Human Retrovirology New York. W.A. Blattner (Ed.).
24. Sun J.Y., Miller M.M., Goto R.M., Rodriguez R., Forman S.J., Senitzer D. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004, 64:462-468. GL.
25. Vilches C C.J., Gómez-Lozano N., Estefanía E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 2007, 70:415-422.
26. Jones DC E.R., Ahmad T., Cummings J.R., Jewell D.P., Trowsdale J., Young N.T. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun 2006, 7:576-582.
27. Mao X., Bigham A., Mei R., Gutierrez G., Weiss K., Brutsaert T., et al. A Genomewide Admixture Mapping Panel for Hispanic/Latino populations. Am J Hum Genet 2007, 80:1171-1178.
28. Choudhry S., Tang H., Salari K., Lind D., Clark S.L., et al. Genetics of Asthma in Latino Americans GALA Study: population stratification confounds genetic association studies among Latinos. Hum Genet 2006, 118. CN, 652.
29. Price A.L., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909. PN.
30. Jennes W., Demanet C., Adjé-Touré C.A., Vuylsteke B., Nkengasong J.N., Kestens L. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 2006, 177:6588-6592. VS.
31. Kaslow R.A., McNicholl J.M., Hill A.V.S. Genetic Susceptibility to Infectious Diseases 2008, Oxford University Press, New York.
32. Martin M.P., Gao X., Yamada E., Martin J.N., Pereyra F., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007, 39:733-740. QY.
33. Saito M., Goon P., Hanon E., Taylor G.P., Saito A., et al. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers. Blood 2003, 102:577-584. BV.
34. + lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol 2004, 173:5121-5129. HA.